PIRAMAL PHARMA
Back to Income Statement
|
PIRAMAL PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹8,869 Cr | ₹9,151 Cr | ₹8,171 Cr | ₹7,082 Cr | ₹6,559 Cr |
What is the latest Revenue of PIRAMAL PHARMA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹8,869 Cr |
| Mar2025 | ₹9,151 Cr |
| Mar2024 | ₹8,171 Cr |
| Mar2023 | ₹7,082 Cr |
| Mar2022 | ₹6,559 Cr |
How is Revenue of PIRAMAL PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹8,869 Cr | -3.08 | |
| Mar2025 | ₹9,151 Cr | 11.99 | |
| Mar2024 | ₹8,171 Cr | 15.39 | |
| Mar2023 | ₹7,082 Cr | 7.97 | |
| Mar2022 | ₹6,559 Cr | - | |
Compare Revenue of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹28,130.4 Cr | 0.4% | 16.6% | 10.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹458,249.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,891.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹115,927.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 0.4% |
16.6% |
10.7% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses